What are the likely causes of arm pain after an intravenous hydration infusion and how should it be assessed and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Arm Pain After IV Hydration

Arm pain following IV hydration is most commonly caused by infiltration (fluid leaking into surrounding tissue), phlebitis (vein inflammation), or hematoma formation from vessel injury during cannulation, and requires immediate assessment to prevent progression to tissue damage or thrombosis. 1

Immediate Assessment Steps

When a patient reports arm pain after IV hydration, stop the infusion immediately to prevent progression of complications 1. The key is to rapidly differentiate between the three most common causes:

Clinical Presentation by Cause

Infiltration presents with:

  • Swelling, bruising, and pain at or around the IV site 2
  • The needle tip has perforated the vein wall, allowing fluid to leak into tissue 2
  • Pain is often the first sign that patients notice 3
  • May progress to tissue necrosis if unrecognized 3, 4

Hematoma manifests with:

  • Obvious discoloration and swelling 1
  • Results from blood leaking around the puncture site during or after cannulation 2
  • Can vary from small diffuse areas to large firm masses 2
  • Large hematomas can compress vessels and cause thrombosis 2

Phlebitis (vein inflammation) presents with:

  • Pain along the vein, redness, and warmth 5
  • Occurs in approximately 31% of peripheral IV catheter placements 5
  • Risk factors include female gender, forearm insertion, longer dwelling time, and antibiotic infusions 5, 6

Initial Management Algorithm

Step 1: Stop and Assess

  • Stop the infusion immediately when swelling, pain, or redness is observed 1
  • Leave the cannula in place initially only if you need to aspirate infiltrated fluid, then remove it promptly 1
  • Position the patient flat with the exit site below heart level to reduce air embolism risk 7

Step 2: Apply Local Measures

  • Apply ice to the affected area for 10-15 minutes 1
  • Elevate the limb while monitoring for symptom progression 1
  • If bleeding is present, apply direct pressure for at least 5 minutes, but never occlude the outflow distal to the bleeding site as this increases intraluminal pressure to arterial levels 2, 1

Step 3: Monitor for Progression

  • Check vital signs (temperature, pulse, blood pressure, respiratory rate) every 4 hours to detect systemic complications 1, 7
  • Document the extent of swelling, discoloration, and pain 2
  • Reassess frequently for the first 24-48 hours 2

When to Escalate Care

Order urgent duplex ultrasound if:

  • Unilateral arm swelling develops, indicating possible upper extremity deep vein thrombosis (UEDVT) 1
  • Pain persists or worsens despite initial management 2

Order chest X-ray if:

  • Patient develops dyspnea or chest wall pain to rule out air embolism or other complications 1, 7

Refer to vascular surgery if:

  • A very large hematoma develops that may require CVC placement and deferral of further access attempts for up to 3 months 2
  • Bleeding requires skin suture placement, which is highly suggestive of venous outflow stenosis 2
  • Signs of limb-threatening ischemia develop (though rare with peripheral IV) 8

Prevention Strategies for Future Access

To minimize recurrence, implement these evidence-based practices:

  • Select large veins in the forearm for peripheral administration, avoiding joints, inner wrist, lower extremities, or areas with poor venous access 1
  • Use flexible cannulae rather than winged steel "butterfly" needles 1
  • Consider Vialon catheters over Teflon, as phlebitis incidence is lower (27% vs 33%) 5
  • Check for blood return before administering medications and regularly throughout infusions 1
  • Avoid insertion around the elbow, which increases phlebitis risk 6
  • Minimize the number of insertion attempts, as multiple attempts increase phlebitis rates 6

Critical Pitfalls to Avoid

  • Never apply pressure distal to an infiltration site, as this increases intraluminal pressure and worsens the infiltration 1
  • Never dismiss unilateral swelling as benign—it indicates obstruction requiring urgent evaluation for UEDVT 1
  • Never delay assessment for potential complications such as air embolism or bleeding 7
  • Do not underestimate infiltration as a "natural consequence" of IV therapy—every effort should be made to prevent it 9

Special Considerations

For patients requiring continued IV access:

  • Avoid the affected arm until symptoms completely resolve 2
  • If a large hematoma developed, wait up to 3 months before attempting access in that area 2
  • Consider alternative access sites or central venous access if peripheral options are exhausted 7

Documentation requirements:

  • Record the event details, including site appearance, interventions performed, and patient response 2
  • Accurate documentation is vital for patient care continuity and potential litigation 3

References

Guideline

Management of Complications After IV Line Placement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

kdoqi clinical practice guideline for vascular access: 2019 update.

American Journal of Kidney Diseases, 2020

Research

IV therapy: recognizing the differences between infiltration and extravasation.

British journal of nursing (Mark Allen Publishing), 2008

Research

Infiltration and extravasation.

The American journal of nursing, 2007

Guideline

Management of a Patient Who Has Self-Removed a PICC Line

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

clinical practice guidelines for vascular access.

American Journal of Kidney Diseases, 2006

Research

Intravenous complication: infiltration.

Journal of intravenous nursing : the official publication of the Intravenous Nurses Society, 2000

Related Questions

Is applying a warm compress to an infiltrated intravenous line beneficial or detrimental?
What is the difference between infiltration and extravasation in peripheral intravenous therapy?
How should a lidocaine infusion infiltration at a peripheral intravenous (IV) line be treated?
What is the management for an infiltrated intravenous (IV) line infusing lipids?
What is the treatment for intravenous (IV) phenylephrine infiltrate?
What are the recommended dose, contraindications, adverse effects, monitoring parameters, and alternative treatments for Salagen (pilocarpine) in patients with symptomatic xerostomia from head‑and‑neck radiation or Sjögren’s syndrome?
For a 7‑year‑old child with PANS/PANDAS whose motor or vocal tics and OCD improve with anti‑inflammatory therapy but flare when the medication is stopped or during viral upper‑respiratory infections, what is the role of intravenous immunoglobulin (IVIG) and when should it be initiated?
In a patient with Hashimoto’s thyroiditis who has a goiter but normal thyroid‑stimulating hormone and free thyroxine levels, what is the appropriate next step in management?
Are there any studies on Japanese knotweed for the treatment or prevention of tick‑borne infections such as Lyme disease, anaplasmosis, babesiosis, or ehrlichiosis?
At what time of day should quetiapine be administered to an elderly patient with dementia who has sundowning-related agitation and visual hallucinations?
What is the medical term for overlapping toes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.